1. Home
  2. ASBPW vs COHU Comparison

ASBPW vs COHU Comparison

Compare ASBPW & COHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASBPW
  • COHU
  • Stock Information
  • Founded
  • ASBPW N/A
  • COHU 1947
  • Country
  • ASBPW United States
  • COHU United States
  • Employees
  • ASBPW N/A
  • COHU N/A
  • Industry
  • ASBPW Biotechnology: Pharmaceutical Preparations
  • COHU Electrical Products
  • Sector
  • ASBPW Health Care
  • COHU Industrials
  • Exchange
  • ASBPW Nasdaq
  • COHU Nasdaq
  • Market Cap
  • ASBPW N/A
  • COHU N/A
  • IPO Year
  • ASBPW 2022
  • COHU N/A
  • Fundamental
  • Price
  • ASBPW N/A
  • COHU $14.06
  • Analyst Decision
  • ASBPW
  • COHU Buy
  • Analyst Count
  • ASBPW 0
  • COHU 7
  • Target Price
  • ASBPW N/A
  • COHU $30.67
  • AVG Volume (30 Days)
  • ASBPW N/A
  • COHU 650.6K
  • Earning Date
  • ASBPW N/A
  • COHU 05-01-2025
  • Dividend Yield
  • ASBPW N/A
  • COHU N/A
  • EPS Growth
  • ASBPW N/A
  • COHU N/A
  • EPS
  • ASBPW N/A
  • COHU N/A
  • Revenue
  • ASBPW N/A
  • COHU $401,779,000.00
  • Revenue This Year
  • ASBPW N/A
  • COHU $11.41
  • Revenue Next Year
  • ASBPW N/A
  • COHU $17.10
  • P/E Ratio
  • ASBPW N/A
  • COHU N/A
  • Revenue Growth
  • ASBPW N/A
  • COHU N/A
  • 52 Week Low
  • ASBPW N/A
  • COHU $12.57
  • 52 Week High
  • ASBPW N/A
  • COHU $36.60
  • Technical
  • Relative Strength Index (RSI)
  • ASBPW N/A
  • COHU 38.74
  • Support Level
  • ASBPW N/A
  • COHU $13.55
  • Resistance Level
  • ASBPW N/A
  • COHU $14.80
  • Average True Range (ATR)
  • ASBPW 0.00
  • COHU 0.99
  • MACD
  • ASBPW 0.00
  • COHU 0.14
  • Stochastic Oscillator
  • ASBPW 0.00
  • COHU 51.38

About ASBPW Aspire Biopharma Holdings Inc. Warrant

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: